Pub Date : 2025-08-27DOI: 10.1038/d41573-025-00140-9
Katie Kingwell
{"title":"Transport vehicle delivers antibodies to the brain","authors":"Katie Kingwell","doi":"10.1038/d41573-025-00140-9","DOIUrl":"10.1038/d41573-025-00140-9","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 10","pages":"740-740"},"PeriodicalIF":101.8,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144905900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-14DOI: 10.1038/d41573-025-00139-2
Asher Mullard
Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development. Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.
Howard Chang,安进的新CSO,讨论基因靶点的发现,染色体外DNA和技术的发展。
{"title":"From gene hunter to drug hunter","authors":"Asher Mullard","doi":"10.1038/d41573-025-00139-2","DOIUrl":"10.1038/d41573-025-00139-2","url":null,"abstract":"Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development. Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 9","pages":"658-659"},"PeriodicalIF":101.8,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00139-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144839988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-12DOI: 10.1038/d41573-025-00135-6
Katie Kingwell
{"title":"Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease","authors":"Katie Kingwell","doi":"10.1038/d41573-025-00135-6","DOIUrl":"10.1038/d41573-025-00135-6","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 10","pages":"729-729"},"PeriodicalIF":101.8,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00135-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144826021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}